Stocktoria
Taysha Gene Therapies, Inc. TSHA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-24
Taysha Gene Therapies, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,742,449 | $26.3M | 3.67% |
| D. E. Shaw & Co., Inc. | 4,427,301 | $19.8M | 1.38% |
| MILLENNIUM MANAGEMENT LLC | 3,281,820 | $14.7M | 1.03% |
| TWO SIGMA INVESTMENTS, LP | 742,081 | $3.3M | 0.23% |
| CITADEL ADVISORS LLC | 506,835 | $2.3M | 0.16% |
| Point72 Asset Management, L.P. | 461,856 | $2.1M | 0.14% |
| RENAISSANCE TECHNOLOGIES LLC | 413,203 | $1.8M | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 177,309 | $792,571 | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.